Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PEDRO TOMAS RAMIREZ and LARISSA ALEJANDRA MEYER.
PEDRO TOMAS RAMIREZ
Connection Strength
6.342
LARISSA ALEJANDRA MEYER
  1. A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. Am J Obstet Gynecol. 2021 01; 224(1):70.e1-70.e11.
    View in: PubMed
    Score: 0.760
  2. Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508.
    View in: PubMed
    Score: 0.691
  3. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol. 2018 08; 132(2):281-290.
    View in: PubMed
    Score: 0.664
  4. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients. Gynecol Oncol. 2015 Mar; 136(3):440-5.
    View in: PubMed
    Score: 0.521
  5. Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement. Int J Gynecol Cancer. 2023 Dec 20.
    View in: PubMed
    Score: 0.241
  6. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. Am J Obstet Gynecol. 2024 Feb; 230(2):241.e1-241.e18.
    View in: PubMed
    Score: 0.238
  7. Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023 08; 229(2):140.e1-140.e7.
    View in: PubMed
    Score: 0.231
  8. Secondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer. 2023 05 01; 33(5):749-754.
    View in: PubMed
    Score: 0.231
  9. Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer. 2023 02 06; 33(2):271-277.
    View in: PubMed
    Score: 0.227
  10. Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience. Int J Gynecol Cancer. 2022 Oct 06.
    View in: PubMed
    Score: 0.222
  11. Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery. Int J Gynecol Cancer. 2021 07; 31(7):1052-1060.
    View in: PubMed
    Score: 0.202
  12. Effect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery. Gynecol Oncol. 2021 02; 160(2):464-468.
    View in: PubMed
    Score: 0.195
  13. Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery. Int J Gynecol Cancer. 2021 01; 31(1):114-121.
    View in: PubMed
    Score: 0.194
  14. Enhanced recovery for obese patients undergoing gynecologic cancer surgery. Int J Gynecol Cancer. 2020 10; 30(10):1595-1602.
    View in: PubMed
    Score: 0.191
  15. Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. Int J Gynecol Cancer. 2019 11; 29(9):1417-1424.
    View in: PubMed
    Score: 0.180
  16. Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. Am J Obstet Gynecol. 2020 01; 222(1):66.e1-66.e9.
    View in: PubMed
    Score: 0.178
  17. Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program. Gynecol Oncol. 2019 06; 153(3):604-609.
    View in: PubMed
    Score: 0.173
  18. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500.
    View in: PubMed
    Score: 0.173
  19. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 04; 145(1):55-60.
    View in: PubMed
    Score: 0.149
  20. Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study. Can J Anaesth. 2022 12; 69(12):1477-1492.
    View in: PubMed
    Score: 0.055
  21. Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer. Int J Gynecol Cancer. 2022 Jul 08.
    View in: PubMed
    Score: 0.054
  22. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78.
    View in: PubMed
    Score: 0.052
  23. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol. 2021 10 01; 138(4):565-573.
    View in: PubMed
    Score: 0.052
  24. Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway. Gynecol Oncol. 2021 10; 163(1):191-198.
    View in: PubMed
    Score: 0.051
  25. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118.
    View in: PubMed
    Score: 0.050
  26. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol. 2021 04; 161(1):104-112.
    View in: PubMed
    Score: 0.049
  27. Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway. Int J Gynecol Cancer. 2021 04; 31(4):569-574.
    View in: PubMed
    Score: 0.049
  28. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019 05; 29(4):651-668.
    View in: PubMed
    Score: 0.043
  29. Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019 06; 153(3):597-603.
    View in: PubMed
    Score: 0.043
  30. Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer. Obstet Gynecol. 2018 09; 132(3):545-554.
    View in: PubMed
    Score: 0.042
  31. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol. 2018 01; 131(1):109-116.
    View in: PubMed
    Score: 0.040
  32. A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol. 2016 05; 141(2):371-378.
    View in: PubMed
    Score: 0.035
  33. Improvement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol. 2015 Sep; 138(3):727-30.
    View in: PubMed
    Score: 0.034
  34. Conversion from robotic surgery to laparotomy: a case-control study evaluating risk factors for conversion. Gynecol Oncol. 2014 Aug; 134(2):238-42.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.